Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             37 results found
no title author magazine year volume issue page(s) type
1 A candidate Ross River virus vaccine: preclinical evaluation Aaskov, John
 1997
 15 12-13 p. 1396-1404
9 p.
 article
2 Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus Yang, Shutong
 1997
 15 12-13 p. 1303-1313
11 p.
 article
3 A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin Herland Berstad, Aud Katrine
 1997
 15 12-13 p. 1473-1478
6 p.
 article
4 An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters Murphy, Brian R.
 1997
 15 12-13 p. 1372-1378
7 p.
 article
5 Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly de Bruijn, Iris A.
 1997
 15 12-13 p. 1323-1329
7 p.
 article
6 A systematic method for evaluating the potential viability of local vaccine producers Milstien, J.
 1997
 15 12-13 p. 1358-1363
6 p.
 article
7 Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice Medaglini, Donata
 1997
 15 12-13 p. 1330-1337
8 p.
 article
8 Critical value of prevalence for vaccination programmes. The case of hepatitis A vaccination in Spain Plans Rubió, Pedro
 1997
 15 12-13 p. 1445-1450
6 p.
 article
9 Delivering active peptides and antigens in non-pathogenic bacteria; recombinant vaccine construction by antigen or recombinant protein expression in Listeria monocytogenes or Lactococcus lactis. 1997
 15 12-13 p. 1487-1488
2 p.
 article
10 Diagnosing Trypanosoma cruzi infection by detecting antibodies specific for new antigens; antigen cloning and expression for use as in Chagas disease diagnosis or as a recombinant vaccine 1997
 15 12-13 p. 1487-
1 p.
 article
11 Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs Gupta, Rajesh K.
 1997
 15 12-13 p. 1341-1343
3 p.
 article
12 Dodecahedral adenoviral complex containing penton bases and optionally fibers; adenovirus vector construction using a baculo virus in Trichoplusia ni or Spodoptera frugiperda insect cell culture, for use as a recombinant vaccine or in gene therapy 1997
 15 12-13 p. 1487-
1 p.
 article
13 Enhanced antibody response in cattle against Leptospira hardjo by intradermal vaccination Samina, Itzchak
 1997
 15 12-13 p. 1434-1436
3 p.
 article
14 Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response Gruber, William C.
 1997
 15 12-13 p. 1379-1384
6 p.
 article
15 Expression of the serine rich Entamoeba histolytica protein (SREHP) in the avirulent vaccine strain Salmonella typhi TY2 χ4297 (Δcya Δcrp Δasd): safety and immunogenicity in mice Zhang, Tonghai
 1997
 15 12-13 p. 1319-1322
4 p.
 article
16 Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants Diez-Delgado, Javier
 1997
 15 12-13 p. 1418-1422
5 p.
 article
17 Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection Cheng, Chi-Hung
 1997
 15 12-13 p. 1353-1357
5 p.
 article
18 Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host Bastien, Nathalie
 1997
 15 12-13 p. 1385-1390
6 p.
 article
19 Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops Hopperus Buma, A.P.C.C.
 1997
 15 12-13 p. 1413-1417
5 p.
 article
20 Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres Men, Ying
 1997
 15 12-13 p. 1405-1412
8 p.
 article
21 Introducing ‘fence’ vaccines Spier, R.E.
 1997
 15 12-13 p. 1289-1290
2 p.
 article
22 In vivo absorption of aluminium-containing vaccine adjuvants using 26Al Flarend, Richard E.
 1997
 15 12-13 p. 1314-1318
5 p.
 article
23 Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties Goto, Norihisa
 1997
 15 12-13 p. 1364-1371
8 p.
 article
24 Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization Prayaga, Sudhirdas K.
 1997
 15 12-13 p. 1349-1352
4 p.
 article
25 Neisseria gonorrhoeae: vaginal clearance and its correlation with resistance to infection in subcutaneous chambers in orally immunized estradiol-primed mice Arko, Robert J.
 1997
 15 12-13 p. 1344-1348
5 p.
 article
26 New immunogenic flavivirus peptide modified at C-terminus; dengue virus, yellow-fever virus, Japanese-encephalitis virus or hepatitis C virus recombinant vaccine expression in Spodoptera frugiperda insect cell culture using a baculovirus vector 1997
 15 12-13 p. 1487-
1 p.
 article
27 Perspectives on FIV vaccine development Elyar, John S.
 1997
 15 12-13 p. 1437-1444
8 p.
 article
28 Prophylaxis of experimental HTLV-I infection in cynomolgus monkeys by passive immunization Akari, Hirofumi
 1997
 15 12-13 p. 1391-1395
5 p.
 article
29 Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine Hu, Liangbiao
 1997
 15 12-13 p. 1466-1472
7 p.
 article
30 Rapid identification of Newcastle disease virus vaccine strains LaSota and B-1 by restriction site analysis of their matrix gene Wehmann, E.
 1997
 15 12-13 p. 1430-1433
4 p.
 article
31 Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin Confer, A.W.
 1997
 15 12-13 p. 1423-1429
7 p.
 article
32 Study of the adjuvant activity of new MDP derivatives and purified saponins and their influence on HIV-1 replication in vitro Krivorutchenko, Yuri L.
 1997
 15 12-13 p. 1479-1486
8 p.
 article
33 Synthetic virus-like particles from new human papilloma virus type-6 and -11 constructs — virus-like particle construction for virus infection characterization and vaccine generation; plasmid pVL1393 expression in Spodoptera frugiperda Sf9 insect culture 1997
 15 12-13 p. 1487-
1 p.
 article
34 Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated? Resti, Massimo
 1997
 15 12-13 p. 1338-1340
3 p.
 article
35 The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design Zhang, Chao
 1997
 15 12-13 p. 1291-1302
12 p.
 article
36 The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures Radford, A.D.
 1997
 15 12-13 p. 1451-1458
8 p.
 article
37 Validation of cold chain procedures suitable for distribution of vaccines by public health programs in the USA Kendal, Alan P.
 1997
 15 12-13 p. 1459-1465
7 p.
 article
                             37 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands